C43H53NO14
807.9 g/mol
Aktif Farmasötik İngredientTehlike
Docetaxel
CAS114977-28-5EC601-339-2
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Doğal Ürün
Birincil Kullanım
Farmasötik ham madde
Docetaxel is an active pharmaceutical ingredient used in the manufacturing of medications. It is a complex organic compound with multiple hydroxyl and ester groups.
Antineoplastic agentTubulin modulatorPharmaceutical manufacturing raw material
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 114977-28-5
İlgili Bileşikler
GüçlüAynı ana yapı
Docetaxel trihydrate
CAS148408-66-6
active pharmaceutical ingredient
GüçlüBenzer yapıBenzerlik 0.89
Docetaxal
CAS125354-16-7
active pharmaceutical ingredient
GüçlüBenzer yapıBenzerlik 0.86
10-Deacetyltaxol
CAS78432-77-6
antineoplastic microtubule stabilizing agent
BenzerBenzer yapıBenzerlik 0.79
((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-((2R,3S)-2-hydroxy-3-((2-methylpropan-2-yl)oxycarbonylamino)-3-phenylpropanoyl)oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate;propan-2-one
CAS1426815-65-7
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.79
Kabazitaksel
CAS183133-96-2
active pharmaceutical ingredient
ReferansAynı kategori
Mephobarbital
CAS115-38-8
anticonvulsant active pharmaceutical ingredient
ReferansAynı kategori
Parametadione
CAS115-67-3
anticonvulsant active pharmaceutical ingredient
ReferansAynı kategori
Ambenonium chloride
CAS115-79-7
cholinesterase inhibitor active pharmaceutical ingredient
Güvenlik Referansı
Tehlike
H315Causes skin irritation
H319Causes serious eye irritation
H341Suspected of causing genetic defects
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
Tanımlayıcılar
IUPAC Adı
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChIKey
ZDZOTLJHXYCWBA-VCVYQWHSSA-N
SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
Eş Anlamlılar (55)
- BEIZRAY
- DOCIVYX
- TXL
- Anhydrous Docetaxel, European Pharmacopoeia (EP)
- Docetaxel (JAN/INN)
- Docetaxolum [INN-Latin]
- Anhydrous Docetaxel
- Anhydrous Docetaxel CRS
- BIND 014
- DOCETAXEL MYLAN
- DOCETAXEL TEVA PHARMA
- Docecad
- Docefrez
- Docetaxel (Standard)
- Docetaxel (as trihydrate)
- Docetaxel - Bio-X trade mark
- Docetaxel Accord
- Docetaxel Kabi
- Docetaxel Teva
- Docetaxel Winthrop
- Docetaxel anhydrous
- Docetaxel intermediate
- Docetaxel, Trihydrate
- Docetaxol
- Docetaxolum
- EmDOC
- Taxceus
- Taxoel
- Taxotere
- Taxotere (Aventis)
- Taxotere (TN)
- docetaxel
- docetaxel 114977-28-5
- docetaxelum
- taxotel